PDK1 and neoplasm: Either loss-of-function mutations of SPOP or gain-of-function mutations of PDK1 in their binding region all attenuate SPOP recognizing and ubiquitinating PDK1, leading to elevat PDK1 protein abundance, AKT kinase activity and benefit of tumor malignancies.